Concert Pharmaceuticals Inc. (CNCE) Gained 6.06% or 0.79 To Price $13.83 On Wednesday


Concert Pharmaceuticals Inc. (CNCE) gained 6.06% or 0.79 to $13.83. It is nearly 185089 shares traded, which is 65.49% compare to the average total volume 282612. The market cap of CNCE is $324.03 million. The year to date change is -46.05%. The 52 week price range is from $10.8 to $30.71. Price of CNCE have changed 3.33% during last week. It have changed 3.57% over last month, -7.52% over last 3 months, -32.29% over last 6 months and -48.27% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 14.17. It is 2.46% above current price. The 200-day Moving Averages for CNCE is 17.37. It is 25.60% above current price. The 52-week High is 30.71. It is 122.05% from the current price. The 52-week Low is 10.8. It is -21.91% from current price.

There are some statistics of CNCE. It is has market cap $324.03 million. The share outstanding is 23.43 million. The average volume is 282612. The percent of top 15 Institution holding is 104.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is -21.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is -19.50%.


Tags:

Share this post